Best; Desmond John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Best; Desmond John.The latest application filed is for "piperazine derivative having affinity for the histamine h3 receptor".

Company Profile

0.7.12

Best; Desmond John - Essex GB
Best; Desmond John - Harlow GB
Best; Desmond John - Sandwich Kent GB
Best, Desmond John - Harlow Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperazine derivative having affinity for the histamine H3 receptor Grant 8,288,389 - Best , et al. October 16, 2	2012-10-16
Piperazine Derivative Having Affinity for the Histamine H3 Receptor App 20100204242 - Best; Desmond John ; et al.	2010-08-12
Macrolones--amino substituted quinolones Grant 7,718,621 - Best , et al. May 18, 2	2010-05-18
Piperazine Derivative Having Affinity For The Histamine H3 Receptor App 20090170869 - BEST; Desmond John ; et al.	2009-07-02
Novel Compounds App 20090042862 - Best; Desmond John ; et al.	2009-02-12
Bicyclic benzamide compound as histamine H3 receptor ligand useful in the treatment of neurological diseases Grant 7,446,103 - Best , et al. November 4, 2	2008-11-04
Macrolones - Amino Substituted Quinolones App 20080090773 - Best; Desmond John ; et al.	2008-04-17
Process for the preparation of cephalosporin compounds and synthetic intermediates Grant 7,355,040 - Best , et al. April 8, 2	2008-04-08
Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases App 20070105838 - Best; Desmond John ; et al.	2007-05-10
Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23 Grant 7,045,626 - Best , et al. May 16, 2	2006-05-16
Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies Grant 7,038,055 - Best , et al. May 2, 2	2006-05-02
Aryloxyalkylamine derivatives as h3 receptor ligands App 20060052597 - Best; Desmond John ; et al.	2006-03-09
Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides App 20050288376 - Best, Desmond John ; et al.	2005-12-29
Novel process App 20050165229 - Best, Desmond John ; et al.	2005-07-28
Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 App 20050085505 - Best, Desmond John ; et al.	2005-04-21
Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies App 20050070572 - Best, Desmond John ; et al.	2005-03-31
Process for the preparation of cephalosporin compounds and synthetic intermediates Grant 6,825,344 - Best , et al. November 30, 2	2004-11-30
Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides App 20040024066 - Best, Desmond John ; et al.	2004-02-05
Novel process App 20020058806 - Best, Desmond John ; et al.	2002-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.